Literature DB >> 15703263

A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins.

Brian J Day1, Chirag Kariya.   

Abstract

Manganese porphyrins are a potent class of catalytic antioxidants whose activity was recently shown to be partially dependent upon flavin-containing enzymes (R. Kachadourian et al., 2004, Biochem. Pharmacol. 67, 77-85). We tested whether manganese porphyrins could redox cycle with the flavin-containing enzyme, cytochrome P450 reductase, and whether this results in the inhibition of xenobiotic metabolism. The effect of manganese porphyrins on xenobiotic metabolism in rat and human liver microsomes was assessed spectrofluorometrically by following the O-dealkylation of benzyloxy- (BROD) and methoxyresorufin (MROD). Redox cycling of manganese porphyrins with human cytochrome P450 reductase was assessed both spectrophotometrically and polarographically by following the consumption of NADPH and oxygen, respectively. The tetrakis(N-pyridinium-2-yl) meso-substituted manganoporphyrin, MnTEPyP5+, and the tetrakis(1,3-dimethyl imidazolium-2-yl) meso-substituted manganoporphyrin, MnTDMIP5+, were 40 to 100 times more potent inhibitors of rat and human liver microsomal BROD metabolism than the tetrakis(1,3-diethyl imidazolium-2-yl) meso-substituted manganoporphyrin, MnTDEIP5+, or the tetrakis(4-benzoic acid) meso-substituted manganoporphyrin, MnTBAP. A similar pattern of inhibition was also seen in beta-naphthoflavone-induced rat liver microsomal MROD metabolism. This pattern of xenobiotic metabolism inhibition correlated with the compound's ability to redox cycle with cytochrome P450 reductase where MnTEPyP5+ was more potent than MnTDEIP5+. Furthermore, redox cycling of MnTEPyP5+ with cytochrome P450 reductase was inhibited by the flavin domain inhibitor diphenyleneiodonium. Small changes to the carbon chain length on the imidazolium side groups had a large effect on this activity. It is possible that interactions between manganoporphyrins and flavin-dependent oxidoreductases can account for both adverse and beneficial effects of the compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703263      PMCID: PMC3983945          DOI: 10.1093/toxsci/kfi108

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  40 in total

Review 1.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 2.  Free radicals and phagocytic cells.

Authors:  G M Rosen; S Pou; C L Ramos; M S Cohen; B E Britigan
Journal:  FASEB J       Date:  1995-02       Impact factor: 5.191

3.  Crystal structure solution and refinement of the semisynthetic cobalt-substituted bovine erythrocyte superoxide dismutase at 2.0 A resolution.

Authors:  K Djinovic; A Coda; L Antolini; G Pelosi; A Desideri; M Falconi; G Rotilio; M Bolognesi
Journal:  J Mol Biol       Date:  1992-07-05       Impact factor: 5.469

4.  Molecular actions of a Mn(III)Porphyrin superoxide dismutase mimetic and peroxynitrite scavenger: reaction with nitric oxide and direct inhibition of NO synthase and soluble guanylyl cyclase.

Authors:  S Pfeiffer; A Schrammel; D Koesling; K Schmidt; B Mayer
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

Review 5.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury.

Authors:  A M Choi; J Alam
Journal:  Am J Respir Cell Mol Biol       Date:  1996-07       Impact factor: 6.914

6.  Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.

Authors:  J J McGuire; D J Anderson; B M Bennett
Journal:  J Pharmacol Exp Ther       Date:  1994-11       Impact factor: 4.030

7.  Salen-manganese complexes are superoxide dismutase-mimics.

Authors:  M Baudry; S Etienne; A Bruce; M Palucki; E Jacobsen; B Malfroy
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

8.  Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger.

Authors:  C Szabó; B J Day; A L Salzman
Journal:  FEBS Lett       Date:  1996-02-26       Impact factor: 4.124

Review 9.  Human cytochromes P450: problems and prospects.

Authors:  F J Gonzalez
Journal:  Trends Pharmacol Sci       Date:  1992-09       Impact factor: 14.819

10.  Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury.

Authors:  B J Day; I Fridovich; J D Crapo
Journal:  Arch Biochem Biophys       Date:  1997-11-15       Impact factor: 4.013

View more
  9 in total

1.  Role of reactive oxygen and nitrogen species in olfactory epithelial injury by the sulfur mustard analogue 2-chloroethyl ethyl sulfide.

Authors:  Heidi C O'Neill; David J Orlicky; Tara B Hendry-Hofer; Joan E Loader; Brian J Day; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

2.  Impact of SOD-Mimetic Manganoporphyrins on Spin Trapping of Superoxide and Related Artifacts.

Authors:  Samuel R Schroeder; Carl W White; Tara N Jones; Tara B Hendry-Hofer; Brian J Day; Sandra S Eaton
Journal:  Appl Magn Reson       Date:  2011-02       Impact factor: 0.831

3.  Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells.

Authors:  Melba C Jaramillo; Margaret M Briehl; James D Crapo; Ines Batinic-Haberle; Margaret E Tome
Journal:  Free Radic Biol Med       Date:  2012-02-11       Impact factor: 7.376

4.  Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide.

Authors:  Heidi C O'Neill; Carl W White; Livia A Veress; Tara B Hendry-Hofer; Joan E Loader; Elysia Min; Jie Huang; Raymond C Rancourt; Brian J Day
Journal:  Free Radic Biol Med       Date:  2010-02-04       Impact factor: 7.376

Review 5.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 6.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

7.  Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.

Authors:  Ivan Spasojević; Yumin Chen; Teresa J Noel; Ping Fan; Lichun Zhang; Julio S Rebouças; Daret K St Clair; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-28       Impact factor: 7.376

8.  NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat.

Authors:  Jadwiga Turchan-Cholewo; Vanessa M Dimayuga; Sunita Gupta; R M Charlotte Gorospe; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

9.  Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells.

Authors:  Melba C Jaramillo; Jennifer B Frye; James D Crapo; Margaret M Briehl; Margaret E Tome
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.